Remote Ischemic Conditioning May Aid Recovery after Stroke
Article title: Two weeks of remote ischemic conditioning improves brachial artery flow mediated dilation in chronic stroke survivors Authors: Allison S. Hyngstrom,
Read moreIschemic Stroke
Heart Structure May Play Role in Stroke Risk Disparities Between Black and White People
Researchers have found that differences in the left atrium in the hearts of Black people and white people may play a role in risk of stroke, according to a new study published in the November 25, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Read moreProtein in blood may predict prognosis, recovery from stroke
Researchers at Mayo Clinic in Florida and collaborators have found that a biomarker in the blood may determine the extent of brain injury from different types of strokes and predict prognosis in these patients. Their findings are reported in Science Translational Medicine.
Read moreCould Arm Squeezes with Blood Pressure Cuffs Help the Brain Recover After Stroke?
People who are given clot-busting drugs after a stroke may recover better if they also are given a therapy called remote ischemic postconditioning, according to a new study published in the October 7, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. Remote ischemic conditioning is when blood flow, and the oxygen it carries, is stopped and then restored repeatedly by blood pressure cuffs worn on the arms.
Read more
Research shows COVID-19 is an independent risk factor for acute ischemic stroke.
Corresponding Author: Puneet Belani, MD, Assistant Professor at Icahn School of Medicine at Mount Sinai Hospital, Department of Radiology, Neuroradiology.
Read moreIschemic Stroke Rates Decrease During COVID-19 Pandemic
Research reveals fewer people have been admitted to stroke centers in Michigan and northwest Ohio since the onslaught of the COVID-19 pandemic, and significantly fewer patients received a mechanical thrombectomy for their ischemic stroke.
Read moreStudy Reveals New Way to Treat Stroke Using an Already FDA-Approved Drug
Granulocyte colony-stimulating factor (GCSF) is currently used to treat neutropenia due to chemotherapy and has been successfully used for patients who require bone marrow transplants. The study is the first to report on the neuroprotective effect of GCSF in vivo and showed that it improved neurological deficits that occur in the first few days following cerebral ischemia. GCSF improved long-term behavioral outcomes while also stimulating a neural progenitor recovery response in a mouse model.
Read more
Chicago Physician Among Appointed Authors of New Guidelines for Treatment of Ischemic Stroke
Chicago Physician Among Appointed Authors of New Guidelines for Treatment of Ischemic Stroke
Read more